CCT018159（Cat No.:I005894）is a selective small molecule inhibitor of the protein kinase Akt, which plays a crucial role in regulating cell survival, growth, and metabolism. By inhibiting Akt, CCT018159 has the potential to suppress tumor growth and enhance the effectiveness of other cancer therapies. It has shown promise in preclinical studies for treating various cancers, including those resistant to conventional treatments. CCT018159 is being explored in combination with other therapeutic agents to overcome resistance mechanisms and improve clinical outcomes. However, further clinical trials are necessary to assess its safety, efficacy, and potential for widespread use.